Skip to main content
. 2023 Jul 13;129(5):782–790. doi: 10.1038/s41416-023-02344-5

Fig. 2. Identification of differences in immune cell populations between CBR and NR using spectral flow cytometry (CyTEK).

Fig. 2

a Exemplified tSNE visualisation of merged events from PBMCs of NR (n = 6) and CBR (n = 5), before (C1D1) and after therapy (C2D1). b The summarised immune cell composition of PBMCs of NR and CBR, before (C1D1) and after therapy (C2D1). c Fold changes in Treg abundance in response to therapy between NR and CBR. Error bars represent mean with SEM. *p < 0.05. The p-value was calculated by Wilcoxon rank-sum test.